Haloxyfop-methyl

CASRN 69806-40-2

  • IRIS Summary (PDF) (12 pp, 115 K)
  • Status: Haloxyfop-methyl is not being reassessed by IRIS at this time.

Health Hazard Assessments for Effects Other than Cancer


Reference Dose for Oral Exposure (RfD) (PDF) (12 pp, 115 K) last updated: 05/01/1990

RfD (mg/kg-day) System Basis PoD Composite UF Confidence
5 x10-5 Reproductive, Urinary Reduced relative kidney weights in F0, F1, and F2b adults; reduced fertility in the F1/F2b generation NOEL : 5 x10-3
mg/kg-day
100 High

Reference Concentration for Inhalation Exposure (RfC) (PDF) (12 pp, 115 K)
Not assessed under the IRIS Program.

Cancer Assessment


Weight of Evidence for Cancer (PDF) (12 pp, 115 K)
Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (12 pp, 115 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (12 pp, 115 K)

Not assessed under the IRIS Program.

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.